WO2026051995 - ARYLPROPIONIC ACID COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2026/051995
Publication Date
12.03.2026
International Application No.
PCT/CN2025/118927
International Filing Date
04.09.2025
Title **
[English]
ARYLPROPIONIC ACID COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF
[French]
COMPOSÉ D'ACIDE ARYLPROPIONIQUE, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
[Chinese]
芳基丙酸化合物及其制备方法与用途
Applicants **
CHENGDU KANGHONG PHARMACEUTICAL CO LTD
Inventors
WANG, Kai
KE, Xiao
YU, Yongguo
Priority Data
202411240414.1
05.09.2024
CN
202510648248.7
20.05.2025
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2598 | |
| EPO | Filing, Examination, Granting | 18861 | |
| Japan | Filing, Examination, Granting | 2485 | |
| South Korea | Filing, Examination, Granting | 2801 | |
| USA | Filing, Examination, Granting | 6190 |
Total:
32,935
Contact Us
Abstract[English]
The present invention relates to a novel arylpropionic acid compound, or a salt, a solvate, a stereoisomer, or a tautomer thereof. The compound is capable of inhibiting plasma lipoprotein(a) levels. The present invention further relates to a pharmaceutical composition thereof, a preparation method therefor, and a therapeutic use thereof.[French]
La présente invention concerne un nouveau composé d'acide arylpropionique, ou un sel, un solvate, un stéréoisomère, ou un tautomère de celui-ci. Le composé est apte à inhiber les niveaux de lipoprotéine(a) plasmatique. La présente invention concerne en outre une composition pharmaceutique de celui-ci, son procédé de préparation et son utilisation thérapeutique.[Chinese]
涉及一种新的芳基丙酸化合物，或其盐、溶剂化物、立体异构体或互变异构体，所述化合物能够抑制血浆脂蛋白(a)水平；还涉及它们的药物组合物、它们的制备方法以及治疗用途。